The unadjusted comparison did not reach statistical significance (RR 1.13; 95% CI 0.95-1.34; P = 0.18), but after prespecified adjustment for site and baseline eGFR, albumin was associated with a significant increase in AKI risk (adjusted RR 1.12; 95% CI 1.04-1.21; P = 0.003).
1
0.1800
0.1800